Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives
Lucija Levstek, Larisa Janžič, Alojz Ihan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7

Showing 7 citing articles:

Avances en inmunoterapia para leucemia linfocítica aguda: integración de terapias con células car-T y otras estrategias inmunológicas
Vladimir Moreta, Daniela Alexandra Rosero Freire
Bionatura journal : (2025) Vol. 2, Iss. 1, pp. 1-23
Closed Access
Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
Xiang Wang, Wen Shen, Lan Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Radiogenomic Landscape of Metastatic Endocrine-Positive Breast Cancer Resistant to Aromatase Inhibitors
Richard Khanyile, Talent Chipiti, Rodney Hull, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 808-808
Open Access
Cerebrospinal fluid proteomics exerts predictive potential for immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR-T cell therapy
Tomoko Nomiyama, Daiki Setoyama, Ikumi Yamanaka, et al.
Leukemia (2025)
Open Access
Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups
Yasunari Matsuzaka, Ryu Yashiro
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 268-268
Open Access
Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin’s lymphoma
Charlotte Junkuhn, Phillip Schiele, Annette O. Walter, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e010709-e010709
Open Access
Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: where do we stand today?
Xiang Zhou, K. Martin Kortuem, Leo Rasche, et al.
La Presse Médicale (2024), pp. 104265-104265
Open Access | Times Cited: 2
Advancing the next generation of cancer treatment with circular RNAs in CAR-T cell therapy
Sanxiong Huang, Juling Xu, Natalia Baran, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117753-117753
Open Access | Times Cited: 1
Development and Validation of a Novel Four Gene-Pairs Signature for Predicting Prognosis in DLBCL Patients
Atsushi Tanabe, Jerry Ndzinu, Hiroeki Sahara
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12807-12807
Open Access
Page 1

Scroll to top